Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy

The antiviral drug remdesivir has been shown clinically effective for treatment of COVID-19. We here demonstrate suppressive but not curative effect of remdesivir in an immunocompromised patient. A man in his fifties treated with chemoimmunotherapy for chronic lymphocytic leukemia experienced a 9-we...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Infect Dis
Main Authors: Helleberg, Marie, Niemann, Carsten Utoft, Moestrup, Kasper Sommerlund, Kirk, Ole, Lebech, Anne-Mette, Lane, Clifford, Lundgren, Jens
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Brief Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7454684/
https://ncbi.nlm.nih.gov/pubmed/32702095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiaa446
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki